Company intelligence / Profile preview

Xcelerate

Mauldin, South Carolina, United States

Ownership: Private
Employees: ~12
Development stage: Other

Overview

Xcelerate is an active, publicly traded U.S. company (OTCMKTS:XCRT) focused on bridging engineering innovation with clinical care, specializing in consumer health and wellness products (not pure therapeutics), virtual healthcare technology platforms for global patient reach, and licensing/acquisition of medical device and skin care IP

Therapeutic areas: OtherDermatology
Modalities: DeviceVirtual health platformConsumer topical therapies
Industry: Consumable Medical Devices

Partnerships

HS Pharmaceuticals (licensed patent/IP portfolio) — manufacturing/marketing partners actively sought for OTC healthcare product development

Beyond the preview

Go deeper on Xcelerate.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xcelerate.

Explore the full profile